Novo Nordisk - bortfald af semaglutide-patent i Canada 2026?
-
Der er ingen tvivl om, at der findes et marked for de originale og dyre lægemidler, og det er helt i orden. Det, jeg finder problematisk, er hvis staten giver tilskud til alle disse kostbare præparater, for så er det i praksis skatteyderne, der finansierer en del af folks slankekure. Derudover kan det gøre sundhedsforsikringer unødigt dyre, medmindre man får mulighed for at fravælge fedmerelaterede behandlinger i sin forsikring. I stedet bør der indføres højere skatter på alkohol, sukkerprodukter, fastfood og lignende, så disse midler kan øremærkes til blandt andet fedmebehandlinger.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind